Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Artificial Intelligence for Biomarker Discovery and Clinical Trial Optimization
0
Zitationen
7
Autoren
2026
Jahr
Abstract
Biomarkers exist in various forms including molecular and genetic elements as well as imaging techniques and physiological and behavioral and digital markers which function as measurable indicators to track biological processes and disease states and therapeutic responses. These elements establish the basis for precision medicine through their capacity to detect diseases at their earliest stages and to classify risks and disease types and to track treatment results in real-time. Hence plays crucial role in AI field
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.250 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.109 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.482 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.434 Zit.